BLG LLP represented Canaccord Genuity Corp. on the transaction. Tryp Therapeutics Inc. closed its initial public offering of units. A total of 20.01 million units were…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
